FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / earnout-agreement-exhibit.docx
earnout-agreement-exhibit.docx · 1013-00006

Parties

Genome Dx Therapeutics Inc
Brindoval Partners LLC
Harkness LLP
Gregg LLP

Dates

May 11, 2023
August 8, 2023
January 30, 2023
August 8, 2026
August 8, 2025
December 6, 2023
August 8, 2027
September 12, 2019
July 14, 2023
May 8, 2023

Amounts

$140,000,000
$126,000,000
$14,000,000
$8,000,000
$6,000,000
$25,000
$28,000,000
$1,400,000
$75,000

Obligations

Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the APA
1, "clearance" and "approval" shall have the meanings customarily ascribed to such terms in the context of the Federal Food, Drug, and Cosmetic Act, as amended, and applicable FDA regulations
(b) The achievement of Milestone 1 must occur on or before August 8, 2025 (the "Milestone 1 Deadline")
1, Buyer shall pay to Seller the Milestone 1 Payment of Eight Million Dollars ($8,000,000) in accordance with Article III
2(a)(ii) must be satisfied on or before August 8, 2026 (the "Milestone 2 Deadline")
1, Buyer shall pay to Seller the Milestone 2 Payment of Six Million Dollars ($6,000,000) in accordance with Article III